Harbour Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-93
Closed -$1.15K 3689
2024
Q4
$1.15K Buy
93
+86
+1,229% +$985 ﹤0.01% 3141
2024
Q3
$80 Hold
7
﹤0.01% 3324
2024
Q2
$50 Hold
7
﹤0.01% 3237
2024
Q1
$47 Hold
7
﹤0.01% 3174
2023
Q4
$46 Hold
7
﹤0.01% 3088
2023
Q3
$66 Buy
+7
New +$84 ﹤0.01% 2943
2022
Q4
Sell
-2,200
Closed -$34K 3134
2022
Q3
$34K Hold
2,200
﹤0.01% 1426
2022
Q2
$34K Buy
+2,200
New +$32.5K ﹤0.01% 1426
2021
Q4
$64K Hold
2,200
﹤0.01% 1155
2021
Q3
$47K Hold
2,200
﹤0.01% 1809
2021
Q2
$56K Hold
2,200
﹤0.01% 1751
2021
Q1
$40K Buy
+2,200
New +$36.6K ﹤0.01% 1829

Other funds holding CDMO

Harbour Investments's CDMO Position: Q1 2025 in Review

Harbour Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 93 shares — an estimated $1.15K sold.

Harbour Investments first reported a position in CDMO in Q1 2021 and held it in 12 quarters. The position peaked at $64K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Harbour Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Harbour Investments sold 93 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.15K.
  • Harbour Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Harbour Investments's Avid Bioservices, Inc. Common Stock position peaked at $64K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Harbour Investments's 13F filing for Q1 2025, filed 8 May 2025.